<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Gb Sciences Inc — News on 6ix</title>
<link>https://6ix.com/company/gb-sciences-inc</link>
<description>Latest news and press releases for Gb Sciences Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 22 Dec 2022 12:00:40 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/gb-sciences-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835759b78dffbe2df0f6e2b.webp</url>
<title>Gb Sciences Inc</title>
<link>https://6ix.com/company/gb-sciences-inc</link>
</image>
<item>
<title>Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-identifies-novel-cannabis-inspired-mixtures-as-anti-inflammatory-therapies-based-on-proprietary-ai-enabled-drug-discovery-platform</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-identifies-novel-cannabis-inspired-mixtures-as-anti-inflammatory-therapies-based-on-proprietary-ai-enabled-drug-discovery-platform</guid>
<pubDate>Thu, 22 Dec 2022 12:00:40 GMT</pubDate>
<description>Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform.</description>
</item>
<item>
<title>Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-addresses-growing-need-for-anxiety-and-depression-medications-with-non-psychedelic-kava-based-formulations</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-addresses-growing-need-for-anxiety-and-depression-medications-with-non-psychedelic-kava-based-formulations</guid>
<pubDate>Mon, 12 Dec 2022 12:01:11 GMT</pubDate>
<description>Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations.</description>
</item>
<item>
<title>Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-co-publishes-study-demonstrating-anti-inflammatory-properties-of-cannabis-ingredients</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-co-publishes-study-demonstrating-anti-inflammatory-properties-of-cannabis-ingredients</guid>
<pubDate>Tue, 01 Nov 2022 11:01:14 GMT</pubDate>
<description>Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients.</description>
</item>
<item>
<title>TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit</title>
<link>https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-president-demonstrates-benefits-of-ai-enabled-drug-discovery-engine-for-novel-plant-inspired-pharmaceuticals-at-10th-annual-drug-discovery-strategic-summit</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-president-demonstrates-benefits-of-ai-enabled-drug-discovery-engine-for-novel-plant-inspired-pharmaceuticals-at-10th-annual-drug-discovery-strategic-summit</guid>
<pubDate>Thu, 27 Oct 2022 11:01:10 GMT</pubDate>
<description>TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit.</description>
</item>
<item>
<title>Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-plant-based-formulations-designed-to-treat-anxiety-achieve-statistical-significance-in-animal-study</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-plant-based-formulations-designed-to-treat-anxiety-achieve-statistical-significance-in-animal-study</guid>
<pubDate>Mon, 24 Oct 2022 11:01:23 GMT</pubDate>
<description>Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study.</description>
</item>
<item>
<title>TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference</title>
<link>https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-president-demonstrates-effectiveness-of-simplified-therapeutic-mixtures-inspired-by-cannabis-plant-extracts-at-canna-pharma-2022-conference</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-president-demonstrates-effectiveness-of-simplified-therapeutic-mixtures-inspired-by-cannabis-plant-extracts-at-canna-pharma-2022-conference</guid>
<pubDate>Thu, 13 Oct 2022 11:01:46 GMT</pubDate>
<description>TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference.</description>
</item>
<item>
<title>Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-co-publishes-study-demonstrating-efficacy-of-its-proprietary-cannabinoid-mixtures-for-the-treatment-of-parkinsons-disease</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-co-publishes-study-demonstrating-efficacy-of-its-proprietary-cannabinoid-mixtures-for-the-treatment-of-parkinsons-disease</guid>
<pubDate>Mon, 10 Oct 2022 11:00:46 GMT</pubDate>
<description>Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease.</description>
</item>
<item>
<title>TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article</title>
<link>https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-describes-drug-development-progress-in-pharmas-almanac-journal-article</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-describes-drug-development-progress-in-pharmas-almanac-journal-article</guid>
<pubDate>Tue, 06 Sep 2022 13:01:20 GMT</pubDate>
<description>TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article.</description>
</item>
<item>
<title>Gb Sciences is Leading Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-is-leading-digital-transformation-in-biopharma-industry-through-its-novel-ai-accelerated-drug-discovery-platformpharostm</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-is-leading-digital-transformation-in-biopharma-industry-through-its-novel-ai-accelerated-drug-discovery-platformpharostm</guid>
<pubDate>Tue, 19 Jul 2022 13:32:11 GMT</pubDate>
<description>Gb Sciences is Leading Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™.</description>
</item>
<item>
<title>Gb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-leads-digital-transformation-in-biopharma-industry-through-its-novel-ai-accelerated-drug-discovery-platformpharostm</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-leads-digital-transformation-in-biopharma-industry-through-its-novel-ai-accelerated-drug-discovery-platformpharostm</guid>
<pubDate>Mon, 18 Jul 2022 13:02:39 GMT</pubDate>
<description>Gb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™.</description>
</item>
<item>
<title>TODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summit</title>
<link>https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-president-and-chief-science-officer-presents-keynote-address-on-cannabinoid-containing-formulations-for-parkinsons-disease-at-2022-neuroforum-summit</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-president-and-chief-science-officer-presents-keynote-address-on-cannabinoid-containing-formulations-for-parkinsons-disease-at-2022-neuroforum-summit</guid>
<pubDate>Mon, 23 May 2022 13:05:38 GMT</pubDate>
<description>TODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summit.</description>
</item>
<item>
<title>TODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform Summit</title>
<link>https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-showcases-its-pharostm-drug-discovery-platform-at-the-2nd-alcor-drug-discovery-platform-summit</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-showcases-its-pharostm-drug-discovery-platform-at-the-2nd-alcor-drug-discovery-platform-summit</guid>
<pubDate>Thu, 12 May 2022 13:01:18 GMT</pubDate>
<description>TODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform Summit.</description>
</item>
<item>
<title>TODAY: Gb Sciences' Novel Plant-Inspired Pain Medications Featured at SMi's 22nd Annual Pain Therapeutics Conference</title>
<link>https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-novel-plant-inspired-pain-medications-featured-at-smis-22nd-annual-pain-therapeutics-conference</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/today-gb-sciences-novel-plant-inspired-pain-medications-featured-at-smis-22nd-annual-pain-therapeutics-conference</guid>
<pubDate>Thu, 05 May 2022 13:31:12 GMT</pubDate>
<description>TODAY: Gb Sciences' Novel Plant-Inspired Pain Medications Featured at SMi's 22nd Annual Pain Therapeutics Conference.</description>
</item>
<item>
<title>FHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapies</title>
<link>https://6ix.com/company/gb-sciences-inc/news/fhi-clinical-to-write-clinical-trial-protocol-for-development-of-gb-sciences-covid-19-related-anti-inflammatory-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/fhi-clinical-to-write-clinical-trial-protocol-for-development-of-gb-sciences-covid-19-related-anti-inflammatory-therapies</guid>
<pubDate>Mon, 02 May 2022 13:01:14 GMT</pubDate>
<description>FHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapies.</description>
</item>
<item>
<title>Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-to-begin-dosage-study-for-its-novel-parkinsons-disease-formulations-at-the-university-of-lethbridge</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-to-begin-dosage-study-for-its-novel-parkinsons-disease-formulations-at-the-university-of-lethbridge</guid>
<pubDate>Tue, 12 Apr 2022 13:01:14 GMT</pubDate>
<description>Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge.</description>
</item>
<item>
<title>Gb Sciences' Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research Article</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-nanoparticle-encapsulation-technology-improves-the-efficacy-of-terpenes-for-use-in-our-chronic-pain-formulations-as-demonstrated-in-new-research-article</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-nanoparticle-encapsulation-technology-improves-the-efficacy-of-terpenes-for-use-in-our-chronic-pain-formulations-as-demonstrated-in-new-research-article</guid>
<pubDate>Tue, 29 Mar 2022 12:02:09 GMT</pubDate>
<description>Gb Sciences' Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research Article.</description>
</item>
<item>
<title>UPDATE: Gb Sciences Issues Shareholder Letter</title>
<link>https://6ix.com/company/gb-sciences-inc/news/update-gb-sciences-issues-shareholder-letter</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/update-gb-sciences-issues-shareholder-letter</guid>
<pubDate>Wed, 16 Mar 2022 19:02:40 GMT</pubDate>
<description>UPDATE: Gb Sciences Issues Shareholder Letter.</description>
</item>
<item>
<title>Gb Sciences Issues Summary Shareholder Letter</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-issues-summary-shareholder-letter</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-issues-summary-shareholder-letter</guid>
<pubDate>Tue, 15 Mar 2022 11:01:40 GMT</pubDate>
<description>Gb Sciences Issues Summary Shareholder Letter.</description>
</item>
<item>
<title>Gb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary Cystitis</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-granted-us-patent-for-cannabinoid-containing-treatment-for-advanced-heart-disease-trpv1-receptor-associated-hearing-loss-and-urinary-cystitis</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-granted-us-patent-for-cannabinoid-containing-treatment-for-advanced-heart-disease-trpv1-receptor-associated-hearing-loss-and-urinary-cystitis</guid>
<pubDate>Tue, 01 Mar 2022 12:01:10 GMT</pubDate>
<description>Gb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary Cystitis.</description>
</item>
<item>
<title>Gb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus Treatment</title>
<link>https://6ix.com/company/gb-sciences-inc/news/gb-sciences-and-michigan-state-university-researchers-have-identified-the-complicated-truth-behind-the-opportunity-for-an-effective-cannabinoid-based-coronavirus-treatment</link>
<guid isPermaLink="true">https://6ix.com/company/gb-sciences-inc/news/gb-sciences-and-michigan-state-university-researchers-have-identified-the-complicated-truth-behind-the-opportunity-for-an-effective-cannabinoid-based-coronavirus-treatment</guid>
<pubDate>Tue, 01 Feb 2022 12:01:11 GMT</pubDate>
<description>Gb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus Treatment.</description>
</item>
</channel>
</rss>